Clinical trial No longer in our active list Observational Ages 18 to 100

Evaluating brain MRI features in patients with CASPR2 limbic encephalitis

Official title: Brain MRI Longitudinal Volumetric Characteristics Associated With Outcomes of CASPR2-Limbic Encephalitis

Run by Hospices Civils de Lyon · NCT06245447 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study looks at brain MRI scans from patients with CASPR2 limbic encephalitis to see how these images relate to their symptoms and overall health.

Quick facts

Study typeObservational
Ages18 Years to 100 Years
SexAll
Enrollment27 (estimated)
SponsorHospices Civils de Lyon
Academic / other
Locations1 site (Bron)
Trial IDNCT06245447 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals over 50 years old with a confirmed diagnosis of CASPR2-antibody-associated encephalitis and available MRI records.

Probably not a fit

Patients with other antibody positivity against neural or glial antigens or those without sufficient clinical data may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients diagnosed with autoimmune encephalitis associated with anti-CASPR2 antibodies. It aims to conduct a retrospective evaluation of brain MRI characteristics to understand their relationship with clinical outcomes. The study will analyze MRI records from patients who have tested positive for CASPR2 antibodies in their cerebrospinal fluid. By examining these MRI features, the research seeks to provide insights into the progression and manifestations of this rare neurological disorder.

Why it matters

Potential benefit: If successful, this study could enhance understanding of CASPR2 limbic encephalitis and improve diagnostic and treatment strategies for affected patients.

How similar studies have gone: While there is limited data on similar studies, the approach of evaluating MRI characteristics in autoimmune encephalitis is promising and may yield valuable insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with a definite diagnosis of CASPR2-antibody-associated encephalitis
* available MRI records
* Ascertained positivity for CASPR2-antibodies in CSF

Exclusion Criteria:

* Positivity for another antibody against neural or glial antigens
* MRI images not available
* Not enough clinical data to ascertain outcome

Where it's running

  • Hospices Civils de Lyon
    Bron, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.